Flegr J. How and why Toxoplasma makes us crazy. Trends Parasitol. 2013; 29(4): 156-163. https://doi.org/10.1016/j.pt.2013.01.007

Pérez JE, Villada Gomez J, Naranjo Pérez O, Castaño SV. Formas alternas de transmisión de Toxoplasma gondii. Biosalud. 2011; 10(2): 123-137. http://vip.ucaldas.edu.co/biosalud/downloads/Revista_Biosalud_10(2)_COMPLETA.pdf#page=123

Belluco S, Simonato G, Mancin M, Pietrobelli M, Ricci A. Toxoplasma gondii infection and food consumption: a systematic review and meta-analysis of case-controlled studies. Crit Rev Food Sci Nutr. 2018; 58(18): 3085-3096. https://doi.org/10.1080/10408398.2017.1352563

Guo M, Dubey JP, Hill D, Buchanan RL, Gamble HR, Jones JL, et al. Prevalence and risk factors for Toxoplasma gondii infection in meat animals and meat products destined for human consumption. J Food Prot. 2015; 78(2): 457-476. https://doi.org/10.4315/0362-028X.JFP-14-328

da Costa MA, Pinto‐Ferreira F, de Almeida RPA, Martins FDC, Pires AL, Mareze M, et al. Artisan fresh cheese from raw cow's milk as a possible route of transmission in a toxoplasmosis outbreak, in Brazil. Zoonoses Public Health. 2019; 00: 1-8. https://doi.org/10.1111/zph.12660

Lange A, Thyrian J, Wetzka S, Flessa S, Hoffmann W, Zygmunt M, et al. The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study. BMC Pregnancy Childbirth. 2016; 16(197): 1-9. https://doi.org/10.1186/s12884-016-0966-0

Mareze M, do Nascimento Benitez A, Brandão APD, Pinto-Ferreira F, Miura AC, Martins FDC, et al. Socioeconomic vulnerability associated to Toxoplasma gondii exposure in southern Brazil. PLoS One. 2019; 14(2): 1-14. https://doi.org/10.1371/journal.pone.0212375

Bresciani KDS, Galvão ALB, Vasconcellos ALd, Soares JA, Matos LVSd, Pierucci JC, et al. Relevant aspects of human toxoplasmosis. Res J Infect Dis. 2013; 1(1): 1-5. http://dx.doi.org/10.7243/2052-5958-1-7

Egorov AI, Converse R, Griffin SM, Styles J, Klein E, Sams E, et al. Environmental risk factors for Toxoplasma gondii infections and the impact of latent infections on allostatic load in residents of Central North Carolina. BMC Infect Dis. 2018; 18(421): 1-11. https://doi.org/10.1186/s12879-018-3343-y

Belluco S, Mancin M, Conficoni D, Simonato G, Pietrobelli M, Ricci A. Investigating the determinants of Toxoplasma gondii prevalence in meat: a systematic review and meta-regression. PLoS One. 2016; 11(4): 1-24. http://dx.doi.org/10.1371/journal.pone.0153856

Dard C, Fricker-Hidalgo H, Brenier-Pinchart M-P, Pelloux H. Relevance of and New Developments in Serology for Toxoplasmosis. Trends Parasitol. 2016; 32(6): 492-506. https://doi.org/10.1016/j.pt.2016.04.001

Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: A systematic review and meta-analysis. Acta Trop. 2014; 137: 185-194. https://doi.org/10.1016/j.actatropica.2014.05.015

Montoya J, Liesenfeld O. Toxoplasmosis. The Lancet. 2004; 363: 1965-1976. https://doi.org/10.1016/S0140-6736(04)16412-X

Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, et al. Toxoplasma gondii infection in the United States, 2011–2014. Am J Trop Med Hyg. 2018; 98(2): 551-557. https://doi.org/10.4269/ajtmh.17-0677

Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL. Toxoplasmosis: a global threat. J Glob Infect Dis. 2011; 3(3): 281-284. https://www.nureinvestigacion.es/OJS/index.php/nure/article/view/1023

Dubey J. Advances in the life cycle of Toxoplasma gondii. Int J Parasitol. 1998; 28(7): 1019-1024.https://doi.org/10.1016/S0020-7519(98)00023-X

Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13): 1217-1258. https://doi.org/10.1016/S0020-7519(00)00124-7

Peyron F, Lobry JR, Musset K, Ferrandiz J, Gomez-Marin JE, Petersen E, et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect. 2006; 8(9-10): 2333-2340. . https://doi.org/10.1016/j.micinf.2006.03.023

Goldstein EJ, Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008; 47(4): 554-566. https://doi.org/10.1086/590149

Carral L, Kaufer F, Olejnik P, Freuler C, Durlach R. Prevention of congenital toxoplasmosis in a Buenos Aires hospital. Medicina. 2013; 73(3): 238-242. http://www.medicinabuenosaires.com/PMID/23732199.pdf

Robert-Gangneux F. It is not only the cat that did it: how to prevent and treat congenital toxoplasmosis. J Infect. 2014; 68(1): 125-133. https://doi.org/10.1016/j.jinf.2013.09.023

Gómez-Sánchez PI, Arévalo-Rodríguez I, Rubio-Romero JA, Amaya-Guío J, Osorio-Castaño JH, Buitrago-Gutiérrez G. Guías de Práctica Clínica para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto o puerperio: introducción y metodología. Rev Colomb Obstet Ginecol. 2013; 64(3): 234-244. https://doi.org/10.18597/rcog.105

Social MdSyP. Resolución número 3280 Por medio de la cual se adoptan los lineamientos técnicos y operativos de la Ruta Integral de Atención para la Promoción y Mantenimiento de la Salud y la Ruta Integral de Atención en Salud para la Población Materno Perinatal y se establecen las directrices para su operación. 2018. https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%203280%20de%2020183280.pdf

Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A, Schulkin J, et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infect Dis Obstet Gynecol. 2003; 11(3): 139-145. https://doi.org/10.1080/10647440300025512

Ben-Harari RR, Connolly MP. High burden and low awareness of toxoplasmosis in the United States. Postgrad Med. 2019; 131(2): 103-108. https://doi.org/10.1080/00325481.2019.1568792

Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. The lancet. 1997; 349(9063): 1436-1442. https://doi.org/10.1016/S0140-6736(96)07495-8

Bobic B, Šibalić D, Djurkovic-Djakovic O. High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Gynecol Obstet Invest. 1991; 31(3): 182-184. https://doi.org/10.1159/000293151

Gras L, Gilbert R, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. 2004; 132(3): 541-548. https://doi.org/10.1017/S0950268803001948

Cárdenas DM. Seroprevalencia y factores de riesgo asociados a toxoplasmosis gestacional en el Nororiente Colombiano. Mendeley Data, V1. 2022. https://doi.org/10.17632/rwgsysdbgz.1

Deng H, Devleesschauwer B, Liu M, Li J, Wu Y, van der Giessen JW, et al. Seroprevalence of Toxoplasma gondii in pregnant women and livestock in the mainland of China: a systematic review and hierarchical meta-analysis. Sci Rep. 2018; 8(6218): 1-10. https://doi.org/10.1038/s41598-018-24361-8

Mahmoudvand H, Saedi Dezaki E, Soleimani S, Baneshi MR, Kheirandish F, Ezatpour B, et al. Seroprevalence and risk factors of T oxoplasma gondii infection among healthy blood donors in south‐east of Iran. Parasite Immunol. 2015; 37(7): 362-367. https://doi.org/10.1111/pim.12198

Pardini L, Bernstein M, Carral LA, Kaufer FJ, Dellarupe A, Gos ML, et al. Congenital human toxoplasmosis caused by non-clonal Toxoplasma gondii genotypes in Argentina. Parasitol Int. 2019; 68(1): 48-52.https://doi.org/10.1016/j.parint.2018.10.002

Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Org. 2013; 91: 501-508. http://dx.doi.org/10.2471/BLT.12.111732

McLeod R, Lykins J, Noble AG, Rabiah P, Swisher CN, Heydemann PT, et al. Management of congenital toxoplasmosis. Curr Pediatr Rep. 2014; 2(3): 166-194. https://doi.org/10.1007/s40124-014-0055-7

Melamed J, Eckert G, Spadoni V, Lago E, Uberti F. Ocular manifestations of congenital toxoplasmosis. Eye. 2010; 24: 528-534. https://doi.org/10.1038/eye.2009.140

Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. The Lancet. 1999; 353(9167): 1829-1833. https://doi.org/10.1016/S0140-6736(98)08220-8

McCabe R, Chirurgi V. Issues in toxoplasmosis. Infect Dis Clin North Am. 1993; 7(3): 587-604. https://doi.org/10.1016/S0891-5520(20)30544-4

Elsheikha H. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008; 122(4): 335-353. https://doi.org/10.1016/j.puhe.2007.08.009

Trotta M, Borchi B, Zammarchi L, Sterrantino G, Brogi M, Kiros ST, et al. Immunoglobulin M indirect‐fluorescent antibody test for the diagnosis of acute toxoplasmosis during pregnancy in the avidity era: A 14‐year experience at the Tuscany Reference Center for Infectious Diseases in Pregnancy, Florence, Italy. J Obstet Gynaecol Res. 2016; 42(12): 1699-1703. https://doi.org/10.1111/jog.13144

Soares JAS, Caldeira AP. Congenital toxoplasmosis: the challenge of early diagnosis of a complex and neglected disease. Rev Soc Bras Med Trop. 2019; 52(20180228): 1-3. https://doi.org/10.1590/0037-8682-0228-2018

Cárdenas, Lozano C, Castillo Z, Cedeño J, Galvis V, Rios J, et al. Frecuencia de anticuerpos anti Toxoplasma gondii en gestantes de Cúcuta, Colombia. Rev Med Hered. 2015; 26: 230-237. http://www.scielo.org.pe/pdf/rmh/v26n4/a05v26n4.pdf

Gómez Marín JE. Toxoplasmosis: Un problema de salud pública en Colombia. Rev Salud Pública (Bogotá). 2002; 4(1): 7-10. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-00642002000400003

Angel-Müller E, Hougton MP, Eslava C, Riaño J, Rey GE, Gómez-Marín JE. Gestational and congenital toxoplasmosis in two hospitals in Bogota, Colombia. Rev Fac Med Univ Nac Colomb. 2014; 62(2): 179-185. http://dx.doi.org/10.15446/revfacmed.v62n2.45430

Chandramathi S, Nissapatorn V. Prevalence and risk factors of Toxoplasma infection–an update in Malaysian pregnant women. Trop Biomed. 2019; 36(3): 694-702. http://msptm.org/files/Vol36No3/694-702-Nissapatorn-V.pdf

Naheen C, Tarafder S, Khan S. Toxoplasma gondii Seropositivity and its Possible Associated Risk Factors among Pregnant Women Attending Antenatal Clinic in a Tertiary Care Hospital of Dhaka, Bangladesh. Mymensingh Med J. 2018; 27(2): 336-343. https://europepmc.org/article/med/29769499

Ramírez AM, Ríos YK, Galvis NF, Entrena E, Mariño NV, Rangel DM, et al. Seroprevalencia y detección molecular de Toxoplasma gondii en donantes de un banco de sangre de Cúcuta, Colombia. Biomédica. 2019; 39(2): 144-156. https://doi.org/10.7705/biomedica.v39i4.4288

Saki J, Foroutan M, Khodkar I, Khodadadi A, Nazari L. Seroprevalence and molecular detection of Toxoplasma gondii in healthy blood donors in southwest Iran. Transfus Sci. 2019; 58(1): 79-82. https://doi.org/10.1016/j.transci.2018.12.003

Mimica F, Muñoz-Zanzi C, Torres M, Padilla O. Toxoplasmosis, zoonosis parasitaria prevalente en Chile: recuento y desafíos. Rev Chilena Infectol, 2015; 32(5): 541-549. http://dx.doi.org/10.4067/S0716-10182015000600008

Muñoz-Zanzi CA, Fry P, Lesina B, Hill D. Toxoplasma gondii oocyst–specific antibodies and source of infection. Emerg Infect Dis. 2010; 16(10): 1591-1593. http://dx.doi.org/10.3201/eid1610.091674

Jula J, Girones G, Edao B, Deme C, Cebrian J, Butrón L, et al. Seroprevalence of Toxoplasma gondii infection in pregnant women attending antenatal care in southern Ethiopia. Rev Esp Quimioter. 2018; 31(4): 363-366. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172689/pdf/revespquimioter-31-363.pdf

Maldonado YA, Read JS. Diseases CoI. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017; 139(2): 1-53. https://doi.org/10.1542/peds.2016-3860

López-Castillo CA, Díaz-Ramírez J, Gómez-Marín JE. Risk factors for Toxoplasma gondii infection in pregnant women in Armenia, Colombia.Rev Salud Pública (Bogotá). 2005; 7(2): 180-190. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-00642005000200006

Villena I, Aubert D, Gomis P, Ferté H, Inglard J-C, Denis-Bisiaux H, et al. Evaluation of a strategy for Toxoplasma gondii oocyst detection in water. Appl Environ Microbiol. 2004; 70(7): 4035-4039. https://doi: 10.1128/AEM.70.7.4035-4039.2004

Lass A, Pietkiewicz H, Szostakowska B, Myjak P. The first detection of Toxoplasma gondii DNA in environmental fruits and vegetables samples. Eur J Clin Microbiol Infect Dis. 2012; 31: 1101-1108. https://doi.org/10.1007/s10096-011-1414-8

Hussain M, Stitt V, Szabo E, Nelan B. Toxoplasma gondii in the Food Supply. Pathogens 2017; 6(2): 1-7. https://doi.org/10.3390/pathogens6020021

da Silva JG, Alves BHL, Melo RPB, Kim PCP, Neto OLS, Bezerra MJG, et al. Occurrence of anti-Toxoplasma gondii antibodies and parasite DNA in raw milk of sheep and goats of local breeds reared in Northeastern Brazil. Acta Trop. 2015; 142: 145-148. https://doi.org/10.1016/j.actatropica.2014.11.011

Saad NM, Hussein AA, Ewida RM. Occurrence of Toxoplasma gondii in raw goat, sheep, and camel milk in Upper Egypt. Vet World. 2018; 11(9): 1262-1265. https://doi.org/10.14202/vetworld.2018.1262-1265

Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009; 49(6): 878-884. https://doi.org/10.1086/605433

Boughattas S. Toxoplasma infection and milk consumption: Meta-analysis of assumptions and evidences. Crit Rev Food Sci Nutr. 2017; 57(13): 2924-2933. https://doi.org/10.1080/10408398.2015.1084993

Dubey J, Verma S, Ferreira L, Oliveira S, Cassinelli A, Ying Y, et al. Detection and survival of Toxoplasma gondii in milk and cheese from experimentally infected goats. J Food Prot. 2014; 77(10): 1747-1753. https://doi.org/10.4315/0362-028X.JFP-14-167

Koethe M, Schade C, Fehlhaber K, Ludewig M. Survival of Toxoplasma gondii tachyzoites in simulated gastric fluid and cow’s milk. Vet Parasito.l 2017; 233: 111-114. https://doi.org/10.1016/j.vetpar.2016.12.010

Hill D, Dubey J. Update on Toxoplasma gondii as a parasite in food: analysis and control. In Advances in Microbial Food Safety. Volume 2. 2th edition: Elsevier; 2015: 59-80.

Havelaar AH, Haagsma JA, Mangen M-JJ, Kemmeren JM, Verhoef LP, Vijgen SM, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol. 2012; 156(3): 231-238. https://doi.org/10.1016/j.ijfoodmicro.2012.03.029

Hoffmann S, Batz MB, Morris JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012; 75(7): 1292-1302. https://doi.org/10.4315/0362-028X.JFP-11-417

Grether JK, Ashwood P, Van de Water J, Yolken RH, Anderson MC, Torres AR, et al. Prenatal and newborn immunoglobulin levels from mother-child pairs and risk of autism spectrum disorders. Front Neurosci. 2016; 10(218): 1-10. https://doi.org/10.3389/fnins.2016.00218

Sagel U, Krämer A, Mikolajczyk RT. “Blind periods” in screening for toxoplasmosis in pregnancy in Austria–a debate. BMC Infect Dis. 2012; 12(118): 1-4. https://doi.org/10.1186/1471-2334-12-118

Rusindo Hernández N, Ginorio Gavito DE, Álvarez Gainza D, Matamoro Rodríguez DdlC, Castellanos Santos I. Conocimientos sobre toxoplasmosis de las mujeres en edad fértil de un consultorio médico en Trinidad. Rev Cubana Med Gen Integr. 2014; 30: 217-224. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252014000200007

Tomasoni L, Messina G, Genco F, Scudeller L, Prestia M, Spinoni V, et al. Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study. Clin Microbiol Infect. 2019; 25(6): 769-713. https://doi.org/10.1016/j.cmi.2018.09.024

MdS. Resolución número 8430 por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. 1993. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF